We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04765449
Recruitment Status : Active, not recruiting
First Posted : February 21, 2021
Last Update Posted : August 16, 2022
Sponsor:
Collaborator:
Tevogen Bio Inc
Information provided by (Responsible Party):
Thomas Jefferson University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : July 29, 2022
Estimated Study Completion Date : January 14, 2023